Heidelberg Pharma AG (HPHA.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap134.41M
Enterprise Value120.59M
P/E Ratio-3.07
PEG Ratio0.05
Price/Sales Ratio38.37
Price/Book Ratio-8.27
Enterprise/Revenue35.52
Enterprise/EBITDA-2.95

Fiscal Year

Fiscal YearNovember 30, 2025
Most Recent QuarterFebruary 28, 2026

Profitability

Profit Margin-12.62
Operating Margin-12.88
AD

Management Effectiveness

Return On Assets-1.32
Return On Equity-54.61

Income Statement

Revenue1.46M
Revenue/Share0.07
Gross Profit-1.63M
EBITDA-44.63M
Net Income-42.28M
Diluted EPS-0.91

Balance Sheet

Total Cash9.26M
Total Cash/Share0.19
Total Debt77,404
Total Debt/Equity-0.01
Current Ratio2.4
Book Value Per Share-0.32

Price History

52-Week Change-43.95
52-Week High4.83
52-Week Low2.33
Moving Average 50 Days2.68
Moving Average 200 Days2.86

Statistics

Average Volume2,685
Shares Outstanding46.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateJuly 18, 2014
AD